x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Proactive - Interviews for investors

Welcome to the Proactive podcast channel – the destination for breaking news on growth companies and up to the minute market coverage. Here we plug you into what’s new and exciting in the world of business.

business investing

All Episodes

00:04:17

Imugene reports promising results in Phase 1b trial...

Proactive - Interviews for investors ·

2024/09/02

Imugene Ltd (ASX: IMU) chief operating officer Brad Glover and CEO Leslie Chong sit down with Proactive’s Tylah Tully to discuss positive results from its Phase 1b clinical trial of azer-cel (azercabtagene zapreleucel), an allogeneic off-the-shelf CD19 CAR T therapy, in patients with relapsed/refractory diffuse large B cell lymphoma (DLBCL). This trial addresses a significant unmet need as all participants had cancer that returned after autologous CAR T therapy. Ten patients have been treated,

en

00:00:59

FTSE starts September on the back foot as miners...

Proactive - Interviews for investors ·

2024/09/02

London's FTSE 100 opened just off the mark as mining companies weighed early on in the first trading day of September. Rio Tinto, Antofagasta and Anglo American were among those under pressure as the market opened as suppressed iron ore and lower copper prices continued to weigh. Rightmove soared in the meantime as news broke Australian-listed REA Group was considering a possible takeover offer for the property portal, sending shares up 25%. Elsewhere, Vertu Motors was among those reporting on

en

00:03:00

Stellar Resources confirms robust Heemskirk Tin...

Proactive - Interviews for investors ·

2024/09/02

Stellar Resources Ltd (ASX:SRZ, OTC:SLROF) executive chairman Simon Taylor joins Proactive’s Tylah Tully to discuss an updated scoping study for the 100%-owned Heemskirk Tin Project near Zeehan in Western Tasmania, which highlights strong economic potential and supports the initiation of a pre-feasibility study (PFS). The study confirms the project’s potential to deliver solid financial returns over a 12-year mine life, with an average annual production rate of 350,000 tonnes, generating 22,818

en

00:05:32

Novo Resources extends high-grade gold strike at...

Proactive - Interviews for investors ·

2024/09/02

Novo Resources Corp (TSX:NVO, OTCQX:NSRPF, ASX:NVO) executive co-chair and acting CEO Mike Spreadborough joins Proactive’s Tylah Tully to discuss progress at the company’s projects in the Pilbara region of Western Australia. The company has extended the high-grade Main Lode at Nunyerry North to 500 metres of strike, discovering significant gold mineralisation in the process. At the Egina Gold Camp JV, partner De Grey Mining is advancing the Becher Project with substantial drilling activities while

en

00:06:44

WIN Metals acquires Palm Springs Gold Project in...

Proactive - Interviews for investors ·

2024/09/02

WIN Metals Ltd (ASX:WIN) managing director Steve Norregaard joins Proactive’s Tylah Tully to discuss its acquisition of the Palm Springs Gold Project in the Kimberley region of Western Australia. The company has signed an agreement to acquire the prospective project from Meteoric Resources NL (ASX:MEI). The project includes a mineral resource estimate of 5.6 million tonnes at 2.0 g/t gold, totalling 357,000 ounces, and a production history of 52,000 ounces between 1995 and 1997. WIN Metals intends

en

00:06:24

Uneventful week for Bitcoin as Musk's Dogecoin saga...

Proactive - Interviews for investors ·

2024/08/30

Proactive's Billy Farrington takes Stephen Gunnion through recent movements in the cryptocurrency market, particularly focusing on Bitcoin. Farrington highlighted that Bitcoin experienced a volatile week, with prices dropping by 5% against the dollar, driven by ongoing recession fears in the U.S. and significant outflows from Bitcoin exchange-traded funds (ETFs).He explained that these ETF outflows, which totalled approximately $300 million, added downward pressure on Bitcoin prices. However,

en

00:01:10

FTSE100 eyes new record; Nvidia continues slide; Govt...

Proactive - Interviews for investors ·

2024/08/30

The FTSE enjoyed a bright start on Friday, gaining 31 points to reach 8,411. This took the index ever closer to its record high seen in May of 8,447 in intraday trading and an 8,445 close. The move up came despite little company news and another tough night for Nvidia. Traditional safe stocks such as utilities and property groups were going well in early trades, particularly Land Securities and power group SSE. Nvidia shed almost US$200 billion of its value overnight after investors digested its

en

00:05:37

archTIS reports record revenue growth and strong cash...

Proactive - Interviews for investors ·

2024/08/29

archTIS Ltd (ASX:AR9) CEO Daniel Lai joins Proactive’s Tylah Tully to discuss its 2024 financial year, which was highly successful with the company reporting a 54% increase in revenue and a positive operating cash flow of A$1.6 million. archTIS is known for its secure collaboration solutions for sensitive information and achieved record-breaking cash receipts of more than A$12 million, a 159% increase compared to 2023. This growth was driven by significant increases in both licensing and service

en

00:06:32

Reconnaissance Energy Africa CEO Brian Reinsborough...

Proactive - Interviews for investors ·

2024/08/29

Reconnaissance Energy Africa CEO Brian Reinsborough joined Steve Darling from Proactive to provide an update on the company’s financial performance for the recent quarter, highlighting several key developments. Reinsborough discussed the progress on the Naingopo exploration well, which has reached a depth of over 2,400 meters (7,875 feet). This well is a significant project, targeting 181 million barrels of unrisked prospective light/medium oil resources or 937 billion cubic feet of prospective

en

00:06:48

BioHarvest Sciences Q2 Revenue Surpasses $6 Million;...

Proactive - Interviews for investors ·

2024/08/29

BioHarvest Sciences CEO Ilan Sobel joined Steve Darling from Proactive to discuss the company’s impressive financial and operational results for the second quarter of 2024. For the first time, BioHarvest Sciences reported revenue surpassing the $6 million mark, reaching $6.03 million. This represents a 119% increase compared to the $2.8 million reported in the same quarter the previous year, and a 13% sequential growth from the first quarter of 2024. Sobel highlighted that the company's gross

en

00:05:43

Firefly Neuroscience forms game changing partnership...

Proactive - Interviews for investors ·

2024/08/29

Firefly Neuroscience Executive Chair Dave Johnson joined Steve Darling from to announce the company's strategic partnership with the Neurology Consultants of Dallas (NCD). This collaboration aims to enhance early detection efforts and improve disease management for patients experiencing cognitive decline. Johnson explained that NCD will integrate Firefly's Brain Network Analytics (BNA) technology into their patient workflow. This partnership also includes conducting clinical studies to identify

en

00:01:10

FTSE 100 makes early gains; shrugs off Nvidia share...

Proactive - Interviews for investors ·

2024/08/29

The FTSE 100 inched higher in early trades as investors mulled the share price slide in Nvidia overnight despite more impressive numbers.London’s blue-chip index was up eight at 8,352 though Nvidia shares fell almost 7% in overnight trading. This was as sales more than doubled over the second quarter to US$30 billion with guidance of US32.5 billion for the third. Here, Imperial Brands eased lower as the government is said to be considering a wider ban on smoking to include outdoor areas such as

en

00:04:16

Surefire Resources advances Victory Bore with key...

Proactive - Interviews for investors ·

2024/08/29

Surefire Resources NL (ASX:SNR) managing director Paul Burton joins Proactive’s Tylah Tully to discuss progress at the Victory Bore Vanadium Project. The company has made a series of strategic agreements - a joint cooperation agreement (JCA) with Mid West Ports Authority and a heads of agreement with DRA Global Ltd for a total engineering services package.The JCA with the Ports Authority aims to secure port access and logistics solutions for the export of 1.25 million tonnes per annum of magnetite

en

00:02:34

Elixir Energy reports successful flowback at...

Proactive - Interviews for investors ·

2024/08/29

Elixir Energy (ASX:EXR, OTC: ELXPF) managing director Neil Young joins Proactive’s Tylah Tully to discuss developments at the Daydream-2 well within Project Grandis in Queensland's Taroom Trough. The well is now in the clean-up phase, with gas and completion fluid flowing back to the surface without assistance after the successful removal of all temporary plugs across its six stimulated zones. Thus far, 4,300 barrels of the 10,392 barrels of stimulation fluid pumped have been recovered. The Coil

en

00:05:09

Ocean Power Technologies Expands Global Footprint,...

Proactive - Interviews for investors ·

2024/08/28

Ocean Power Technologies CEO Philipp Stratmann joined Steve Darling from Proactive to discuss the company's significant global expansion and the strategic initiatives driving its success. Stratmann provided an update on ongoing projects in key regions such as the Middle East and Latin America, where there is a growing demand for the company's advanced buoy systems and autonomous vehicles.He emphasized the importance of demonstrating their cutting-edge technology in real-world settings, which has

en

00:05:50

Theralase Explores Synergistic Drug Combinations for...

Proactive - Interviews for investors ·

2024/08/28

Theralase Technologies CEO Roger DuMoulin-White joined Steve Darling from Proactive to announce a significant advancement in cancer treatment. The company's lead drug formulation, Rutherrin, has demonstrated a remarkable ability to enhance the efficacy of Cisplatin, a commonly prescribed chemotherapy drug, in treating chemotherapy-resistant Non-Small Cell Lung Cancer in a preclinical animal model. DuMoulin-White detailed the experimentation process, where mice were divided into two groups: a control

en

00:05:15

Torr Metals Unveils High-Grade Assay Results and New...

Proactive - Interviews for investors ·

2024/08/28

Torr Metals CEO Malcom Dorsey joined Steve Darling from Proactive to reveal final assay results from a total of 33 rock grab samples collected during the company's 2024 reconnaissance programs. These results have identified additional high-grade rock grab assays within the Kirby, Rea, and Clapperton exploration target zones. Notably, a new copper-gold discovery has been made in the northern portion of the Sonic Zone at the Kolos Copper-Gold Project. Dorsey emphasized that these latest results not

en

00:07:49

Paul Romness Discusses OS Therapies' IPO & Clinical...

Proactive - Interviews for investors ·

2024/08/28

OS Therapies CEO Paul Romness joined Steve Darling from Proactive to share news the company has been accepted into Johnson & Johnson Innovation – JLABS, a prestigious platform that supports innovation in the life sciences sector. Through this membership, OS Therapies aims to advance its tunable Antibody Drug Conjugate (ADC) linker-based platform into clinical development. This platform utilizes pH-sensitive linkers and coating technology designed to reduce off-target effects, thereby improving

en

00:06:35

Tonix Pharmaceuticals and Bilthoven Bio Collaborate...

Proactive - Interviews for investors ·

2024/08/28

Dr. Seth Lederman, CEO of Tonix Pharmaceuticals, recently joined Steve Darling from Proactive to discuss the company's collaboration with Bilthoven Biologicals (BBio) to advance TNX-801, Tonix’s promising vaccine candidate for mpox. TNX-801 is a live, replicating, attenuated virus vaccine based on horsepox, currently in preclinical development to prevent both mpox and smallpox. TNX-801 leverages cutting-edge technology with the potential to serve as a viral vector platform, enabling the development

en

00:03:01

Graft Polymer UK CEO discusses strong progress in...

Proactive - Interviews for investors ·

2024/08/28

Graft Polymer (UK) PLC CEO Anthony Tennyson takes Proactive's Stephen Gunnion through the progress the company has made in its commercial collaboration with Awakn Life Sciences. Tennyson explained the collaboration is aimed at developing new therapeutics for trauma-related mental health disorders, including post-traumatic stress disorder (PTSD). He noted that Awakn has successfully identified two aminoindane chemical series as lead candidates, marking a crucial step forward in drug development

en

4,496 results

Similar Podcasts

TaxTalent.com The Golden Rule Podcast

Adam Golden

TaxTalent.com Podcast

Tony Santiago

Handelsblatt Crime - spannende Streitfälle der deutschen Wirtschaft

Ina Karabasz, Solveig Gode, Sönke Iwersen

Deffner und Zschäpitz – Der Wirtschafts-Talk von WELT

WELT

Black Box - La scatola nera della finanza

Guido Brera e Gian Luca Comandini -...